About lycotec

This author has not yet filled in any details.
So far lycotec has created 29 blog entries.

Lycotec CEO Dr Ivan Petyaev is presenting at the Second Symposium on Skin Microbiota in Paris.

Lycotec CEO Dr Ivan Petyaev is presenting at the Second Symposium on Skin Microbiota in Paris. The title of his lecture will be:  Reverse of skin ageing: non invasive print tests for sebum – corneocytes – microbiota. A set of new generation of non invasive skin print tests has been developed to assess age associated [...]

By | May 24th, 2017|Lycotec News|0 Comments

Lycotec to attend 18th ISANH World Congress on Antioxidants in Beirut.

Lycotec CEO Dr Ivan M Petyaev is to attend 18th ISANH World Congress on Antioxidants in Beirut from 3rd - 4th May 2017.  Saint-Joseph University of Beiruit, Lebanon. The aim of the ISANH international congress is to gather all stakeholders in the antioxidants field and to examine their impact on nutrition and health. The majority of participants [...]

By | February 14th, 2017|Lycotec News|0 Comments

Lycotec Patented First Nutra-Pharmaceutical Drug to Treat Infection Behind Cardiovascular Disease

Lycotec Ltd., a biotech company based in Cambridge UK, has filed a patent application for the first drug in the treatment of a bacterial infection which could be involved in the development of atherosclerosis and cardiovascular disease, CVD. […]

By | January 30th, 2017|Lycotec News, Science|0 Comments

Dr Ivan Petyaev features on Channel 4.

Dr Ivan Petyaev, CEO and Founder of Lycotec featured on Channel 4 Superfoods: Seaweed, Blue Cheese and Chork. Channel 4’s Kate finds out if seaweed makes slimmer. Is blue cheese good for our stomach health? And will anyone buy the brand new superfood, Icelandic chork? […]

By | December 10th, 2016|Lycotec News|0 Comments

LYCOTEC to present at 7th World Congress on Targeting Mitochondria

The Scientific Committee of World Mitochondria Society is honored to announce the organisaiton of the 7th World Congress on Targeting Mitochondria at which CEO of Lycotec, Dr Ivan M Petyaev will give a presentation on Carotenoids and mitochondria respiration in health, ageing and pathology. 7th World Congress on Targeting Mitochondria will be held at Hotel Maritim ProArte, Berlin [...]

By | September 23rd, 2016|Uncategorised|0 Comments

LYCOTEC Innovation Enters World Cinema and Glamour

Last week the technology rich innovation anti-ageing beauty chocolate, ESTHECHOC, developed by Cambridge based company Lycotec Ltd., was presented at the 73rd Venice Film Festival. The presentation was made by the Italian distributor partner Last year in Paris ESTHECHOC won two prestigious awards - the Best in Skin category and the Grand Prize - the highest [...]

By | September 14th, 2016|Uncategorised|0 Comments

World’s First Longevity SIRT Chocolate

t-RSV is the molecule of plant polyphenol class which is typically present in red grapes, some berries, cocoa and nuts. There are a number of beneficial health effects of t-RSV from cardioprotective to antidiabetic. However, one of its intriguing properties is the ability to activate a group of SIRT genes. These genes are responsible for [...]

By | June 19th, 2016|Uncategorised|0 Comments

Lycotec to present at Redox World Congress at Institut Pasteur in Paris, France 13-15 June 2016

The Redox World Congress 2016 in Paris will focus on the role of antioxidants as modulators of redox signaling pathways, rather than players that counteract oxidative stress. There will also be discussions of the mechanisms by which cells respond to oxidative stress and prevent cell damage and cell death, with particular focus on neurons and [...]

By | June 6th, 2016|Lycotec News|0 Comments

Ateronon Inventor Ivan Petyaev Launches New Generation of Lycopene for Ageing Population

CAMBRIDGE UK (PRWEB UK) 30 MAY 2016 Dr Ivan Petyaev of Lycotec Ltd is proud to announce that a brand new lycopene product, specifically created for the ageing population and for people with metabolic syndrome and fatty liver, is now available on the market. Ateronon, the Cambridge ‘tomato pill’, a lycopene formulation which inhibits blood [...]

By | May 30th, 2016|Lycotec News|0 Comments

Breakthrough Study Shows New Trans-Resveratrol-Lycopene Combination Is A Game Changer For Diabetic Patients

A controlled human trial comparing a placebo to a patented form of lycopene and trans-resveratrol (t-RSV) formulation, found in MedVitál® Bio-Resveratrol®, showed significant reduction in foot ulcers in diabetic patients. Orebro University Hospital and School of Health and Medical Sciences, Orebro Sweden, conducted the study entitled "Resveratrol Promotes Foot Ulcer Size Reduction in Type 2 [...]

By | May 9th, 2016|Lycotec News|0 Comments